Bloomberg Originals
@business·5.1M subscribers·49.5K videos
Ebola Vaccine 'Highly Effective' Trial Should Continue
Posted
July 31, 2015
Views
2,316
Likes
21
Comments
7
Engagement
1.21%
July 31, 2015
2,316
21
7
1.21%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
2:55Now PlayingJuly 31 -- Merck & Co.’s vaccine for Ebola is “highly effective,” according to an interim analysis from a panel of experts who recommended that a late-stage trial should continue. Bloomberg's Drew Armstrong reports on "Market Makers."
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
